HHS Announces 10 Drugs Subject to Medicare Price Negotiations
On August 29, 2023, the U.S. Department of Health and Human Services (HHS), through the…
Author Aimed Alliance
Congress Requests Information on Regulation of CBD
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI)…
New Resources Support Individuals with Growth Hormone Deficiency
English and Spanish materials include information on growth hormone deficiency symptoms, diagnosis, treatment, and health…
Groups File Amicus Brief to Shed Light on Harmful Drug Sourcing Tactics
WASHINGTON, DC / ACCESSWIRE / August 25, 2023 / Twenty-four organizations representing health care consumers…
Navigating the Future of Digital Therapeutics: CMS’s Emerging Technologies Pathway
In the realm of digital therapeutics, the health care landscape is poised for potential transformation…
SAMHSA’s Fact Sheet Underscores the Potential Risks of CBD
The rising popularity of cannabidiol (CBD) has ignited conversations about its potential benefits, but SAMHSA’s…
Advocacy Organizations Send Letter to Payer Matrix Regarding Its Identification as a “Patient Advocacy” Company
On August 17, 2023, thirty-four organizations sent a letter to Payer Matrix urging it to…
Aimed Alliance’s New Resources on CBD Regulation and Labeling
On Aug. 16, Aimed Alliance published two new resources addressing critical aspects of cannabidiol (CBD)…
CONOZCA SUS DERECHOS: Deficiencia de la hormona del crecimiento
Nueva alerta de recursos — CONOZCA SUS DERECHOS: Deficiencia de la hormona del crecimiento La…
Aimed Alliance Urges Medicare Advantage Plans to Stop Imposing Double-Step Fail-First Policies
On August 9, 2023, Aimed Alliance sent letters to Aetna and UnitedHealthcare urging them to…